Literature DB >> 2859542

Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.

O Gaffori, J M Van Ree.   

Abstract

Small doses of melatonin (0.1-100 ng), injected into the nucleus accumbens of rats, decreased locomotor activity and rearing, and increased grooming and sniffing behaviour when the animals were tested in small test-cages. Larger doses of melatonin appeared to be less effective. The action of melatonin is apparently not mediated by dopaminergic systems, because the behavioural changes were not antagonized by local pretreatment with haloperidol or sulpiride. Injection of serotonin antagonists (methysergide and cyproheptadine) into the nucleus accumbens resulted in similar behavioural changes as was found after treatment with melatonin. Treatment with serotonin and various antidepressant drugs (zimelidine, mianserin, nortriptyline, clomipramine, desipramine) injected into the nucleus accumbens, completely inhibited the melatonin-induced behavioural responses. The antidepressants did not significantly interfere with the decrease of locomotor activity and rearing induced by injection of small doses of the dopamine agonist, apomorphine, into the nucleus accumbens. These results suggest that there is an interrelationship between melatonin and serotonin systems in the nucleus accumbens and showed that various antidepressant drugs, similar to serotonin, antagonized the behavioural effects of melatonin after injection into the nucleus accumbens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859542     DOI: 10.1016/0028-3908(85)90080-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Authors:  Shao-wen Tian; Moshe Laudon; Li Han; Jun Gao; Fu-lian Huang; Yu-feng Yang; Hai-feng Deng
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

2.  Melatonin effects on serotonin synthesis and metabolism in the striatum, nucleus accumbens, and dorsal and median raphe nuclei of rats.

Authors:  J M Míguez; F J Martín; M Aldegunde
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

3.  Distribution of 2-[I]iodomelatonin binding in the brain of Mexican free-tailed bats (Tadarida brasiliensis).

Authors:  Christine Schwartz; Paul Bartell; Vincent Cassone; Michael Smotherman
Journal:  Brain Behav Evol       Date:  2009-02-18       Impact factor: 1.808

4.  Sedative potency and 2-[125I]iodomelatonin binding affinity of melatonin analogues.

Authors:  D Sugden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 5.  Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Authors:  Moshe Laudon; Anat Frydman-Marom
Journal:  Int J Mol Sci       Date:  2014-09-09       Impact factor: 5.923

6.  Impact of Melatonin Deficit on Emotional Status and Oxidative Stress-Induced Changes in Sphingomyelin and Cholesterol Level in Young Adult, Mature, and Aged Rats.

Authors:  Jana Tchekalarova; Zlatina Nenchovska; Lidia Kortenska; Veselina Uzunova; Irina Georgieva; Rumiana Tzoneva
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

Review 7.  Immunologic aspects of migraine: A review of literature.

Authors:  Mehrnaz Salahi; Sina Parsa; Delaram Nourmohammadi; Zahra Razmkhah; Omid Salimi; Mohammadreza Rahmani; Saeid Zivary; Monireh Askarzadeh; Mohammad Amin Tapak; Ali Vaezi; Hamidreza Sadeghsalehi; Shirin Yaghoobpoor; Mehran Mottahedi; Setareh Garousi; Niloofar Deravi
Journal:  Front Neurol       Date:  2022-09-28       Impact factor: 4.086

8.  Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats.

Authors:  Florence Loiseau; Claudine Le Bihan; Michel Hamon; Marie-Hélène Thiébot
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.